These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 16579866

  • 41. Preferential development of CD4 and CD8 T regulatory cells in RasGRP1-deficient mice.
    Chen X, Priatel JJ, Chow MT, Teh HS.
    J Immunol; 2008 May 01; 180(9):5973-82. PubMed ID: 18424717
    [Abstract] [Full Text] [Related]

  • 42. CD8+ T cells induce medullary thymic epithelium and CD4+CD8+CD25+ TCRbeta- thymocytes in SCID mice.
    Pettersson FE, Schneider MK, Andersson J, Grönvik KO.
    Scand J Immunol; 2001 Nov 01; 54(5):506-15. PubMed ID: 11696203
    [Abstract] [Full Text] [Related]

  • 43. Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells.
    Marshall D, Sinclair C, Tung S, Seddon B.
    J Immunol; 2014 Dec 01; 193(11):5525-33. PubMed ID: 25348623
    [Abstract] [Full Text] [Related]

  • 44. Glucocorticoid hormone treatment enhances the cytokine production of regulatory T cells by upregulation of Foxp3 expression.
    Ugor E, Prenek L, Pap R, Berta G, Ernszt D, Najbauer J, Németh P, Boldizsár F, Berki T.
    Immunobiology; 2018 Dec 01; 223(4-5):422-431. PubMed ID: 29223294
    [Abstract] [Full Text] [Related]

  • 45. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells.
    Pacholczyk R, Ignatowicz H, Kraj P, Ignatowicz L.
    Immunity; 2006 Aug 01; 25(2):249-59. PubMed ID: 16879995
    [Abstract] [Full Text] [Related]

  • 46. 2,3,7,8-Tetrachlorodibenzo-p-dioxin and diethylstilbestrol affect thymocytes at different stages of development in fetal thymus organ culture.
    Lai ZW, Fiore NC, Gasiewicz TA, Silverstone AE.
    Toxicol Appl Pharmacol; 1998 Apr 01; 149(2):167-77. PubMed ID: 9571985
    [Abstract] [Full Text] [Related]

  • 47. Development of thymic Foxp3(+) regulatory T cells: TGF-β matters.
    Chen W, Konkel JE.
    Eur J Immunol; 2015 Apr 01; 45(4):958-65. PubMed ID: 25684698
    [Abstract] [Full Text] [Related]

  • 48. Recirculating IL-1R2+ Tregs fine-tune intrathymic Treg development under inflammatory conditions.
    Nikolouli E, Elfaki Y, Herppich S, Schelmbauer C, Delacher M, Falk C, Mufazalov IA, Waisman A, Feuerer M, Huehn J.
    Cell Mol Immunol; 2021 Jan 01; 18(1):182-193. PubMed ID: 31988493
    [Abstract] [Full Text] [Related]

  • 49. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.
    Exp Hematol; 2007 Mar 01; 35(3):416-25. PubMed ID: 17309822
    [Abstract] [Full Text] [Related]

  • 50. Role of IL-2 in rat fetal thymocyte development.
    Varas A, Vicente A, Romo T, Zapata AG.
    Int Immunol; 1997 Oct 01; 9(10):1589-99. PubMed ID: 9352365
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells.
    Bayer AL, Yu A, Malek TR.
    J Immunol; 2007 Apr 01; 178(7):4062-71. PubMed ID: 17371960
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Vagaries of fluorochrome reporter gene expression in Foxp3+ regulatory T cells.
    Schallenberg S, Petzold C, Tsai PY, Sparwasser T, Kretschmer K.
    PLoS One; 2012 Apr 01; 7(8):e41971. PubMed ID: 22879902
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.